PA83 (Benzonatate 200 mg)
Pill imprint PA83 has been identified as Benzonatate 200 mg.
Benzonatate is used in the treatment of cough and belongs to the drug class antitussives. Risk cannot be ruled out during pregnancy. Benzonatate 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PA83 (Benzonatate 200 mg)
Benzonatate
- Imprint:
-
PA83
- Strength:
- 200 mg
- Color:
- Yellow
- Size:
- 12.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antitussives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00555-1883
- Inactive Ingredients:
- D&C Yellow No. 10
gelatin
glycerin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 49999-0552 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More resources
Benzonatate is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
